Publications by authors named "V Torri"

Claim this Profile
P
Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial.
Michele Reni, Marina Macchini, Giulia Orsi, Letizia Procaccio, Giuseppe Malleo, Valter Torri

Lancet· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Danazol and cost-savings in immune thrombocytopenia and in immune thrombotic thrombocytopenic purpura.
Mala Varma, Ilan Shapira, Mark Friedman, Ibrahim Nakhoul, Vamsee Torri

Blood Coagul Fibrinolysis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.
Alessio Amatu, Giorgio Patelli, Maria Giulia Zampino, Francesca Bergamo, Stefania Mosconi, Valter Torri

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis.
Fabio Salomone, Massimo Di Maio, Angela Viggiano, Luigi Liguori, Carminia Maria Della Corte, Valter Torri

Crit Rev Oncol Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular and functional landscape of resistance to FOLFIRI chemotherapy in metastatic colorectal cancer.
Marco Avolio, Simonetta M Leto, Francesco Sassi, Barbara Lupo, Elena Grassi, Valter Torri

Cancer Discov· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis